Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fumagalli

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Iscience|December 4, 2023
Airway epithelial cells and macrophages trigger IL-6-CD95/CD95L axis and mediate initial immunopathology of COVID-19Thais F C Fraga-Silva, Ualter G Cipriano, Marcilio J Fumagalli, et al.
Nature Communications|August 17, 2022
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion proteinJulia T Castro, Patrick Azevedo, Marcílio J Fumagalli, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trialMarcilio J Fumagalli, Anna Kaczynska, Marius Allombert, et al.
Cell Host & Microbe|March 13, 2024
Pathophysiology of chikungunya virus infection associated with fatal outcomesWilliam M de Souza, Marcilio J Fumagalli, Shirlene T S de Lima, et al.
Science (New York, N.Y.)|July 25, 2020
Evolution and epidemic spread of SARS-CoV-2 in BrazilDarlan S Candido, Ingra M Claro, Jaqueline G de Jesus, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Iscience|December 4, 2023
Airway epithelial cells and macrophages trigger IL-6-CD95/CD95L axis and mediate initial immunopathology of COVID-19Thais F C Fraga-Silva, Ualter G Cipriano, Marcilio J Fumagalli, et al.
Nature Communications|August 17, 2022
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion proteinJulia T Castro, Patrick Azevedo, Marcílio J Fumagalli, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trialMarcilio J Fumagalli, Anna Kaczynska, Marius Allombert, et al.
Cell Host & Microbe|March 13, 2024
Pathophysiology of chikungunya virus infection associated with fatal outcomesWilliam M de Souza, Marcilio J Fumagalli, Shirlene T S de Lima, et al.
Science (New York, N.Y.)|July 25, 2020
Evolution and epidemic spread of SARS-CoV-2 in BrazilDarlan S Candido, Ingra M Claro, Jaqueline G de Jesus, et al.
Pageof 2